SynProtX
Large-Scale Proteomics & Graph Neural Networks for Synergistic Drug Combinations

SynProtX is a deep learning model leveraging large-scale proteomics, molecular graphs, and fingerprints to enhance the prediction of synergistic effects in anti-cancer drug combinations.
- Integrates large-scale clinical & cell line proteomics (ProCan-DepMapSanger) and cancer gene expression (DepMap CCLE)
- Graph attention network architecture (SynProtX-GATFP) fusing molecular graphs and chemical fingerprints
- Validated across tissue-specific (Breast, Lung, Ovary, Skin) and large-scale synergy benchmarks (ALMANAC, FRIEDMAN, ONEIL)
- Open-source implementation with reproducible training pipelines and Zenodo-archived model weights

